Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies.

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. Abstract Text:

OBJECTIVE: To evaluate the relationship of ovarian activity on Ca125 production, we studied whether Ca125 production varies during the menstrual cycle both in normal ovulatory women and in women whose ovarian factors are significantly stimulated by multiple follicular development (MFD). Furthermore, since the first 12 weeks of pregnancy is characterized by the enhancement of corpus luteum function mainly in MFD-induced pregnancies, Ca125 levels were also evaluated in the first quarter of pregnancy both in spontaneous and in MFD-induced pregnancies. SUBJECTS: Subjects were normal ovulatory women in the late follicular phase (FP) (N = 20) and in the luteal phase (LP) (N = 20), 32 infertile women submitted to MFD with pure FSH, and 40 pregnant women in which pregnancy occurred spontaneously (N = 20) or after induction of MFD (N = 20). RESULTS AND CONCLUSIONS: In regularly cycling women plasma Ca125 levels were constant during the menstrual cycle. In contrast, in stimulated cycles Ca125 levels were significantly higher (P < 0.0008) in the LP than in the FP. In addition, in these subjects Ca125 levels in the LP were significantly correlated (P < 0.0001, r = 0.686) with E2 plasma levels. These data strongly suggest that an increase in corpus luteum function could be involved in Ca125 production. Since granulosa cells have not been demonstrated to produce Ca125, it can be hypothesized that endometrial or peritoneal cells submitted to exaggerated stimulation by ovarian activity are the source of increased Ca125 secretion. In agreement with this hypothesis, Ca125 levels were significantly higher in the first weeks of spontaneous pregnancies than in the luteal phase and they were also higher in MFD-induced pregnancies than in spontaneous pregnancies (P < 0.001).

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. Publishing Authors By Initials

For similar therapeutics: reproductive techniques research abstracts see: therapeutics: reproductive techniques research

PUBMED ID PMID:

MEDLINE DATE:

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of assisted reproduction and genetics

VOLUME: 12

Page Numbers: 263-8

Journal Abbreviation: J. Assist. Reprod. Genet.

ISSN: 1058-0468

DAY: 17

MONTH: Apr

YEAR: 1995

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9206495

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. Keywords Mesh Terms:

KEYWORDS: Reproductive Techniques

MESH TERMS: blood

Chemical & Substance for Abstract: Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. Information

Substance Name: Follicle Stimulating Hormone

Registry Number: 9002-68-0

Grant and Affiliation Information for Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies.

AFFILIATION: Istituto di Ginecologia Ostetricia e Fisiopatologia della Riproduzione Umana, Ospedale San Giovanni di Dio, Cagliari, Italy.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Assist Reprod Genet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development MFD in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies Related Publications

• "Tenderness-guided" transvaginal ultrasonography: a new method for the detection of deep endometriosis in patients with chronic pelvic pain.
• Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report.
• Detection of benign intracavitary lesions in postmenopausal women with abnormal uterine bleeding: a prospective comparative study on outpatient hysteroscopy and blind biopsy.
• Estimating stroke volume from oxygen pulse during exercise.
• Haemodynamic effect of metaboreflex activation in men after running above and below the velocity of the anaerobic threshold.
• Improvement of vestibular plasticity in the guinea pig with a calcium entry blocker.
• Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies.
• Maturity assessment of compost from municipal solid waste through the study of enzyme activities and water-soluble fractions.
• OC07: Diagnosis of location of deep infiltrating endometriosis by transvaginal tenderness-guided ultrasonography.
• OC168: Transvaginal color Doppler in the detection of ovarian cancer in a large study population: Results of sardinia-navarra (Sa.Na.) group.
• OC198: Sonohistology: the use of simple findings to predict the histological diagnosis in more than 900 adnexal masses evaluated by a single center.
• OC24: The role of magnetic resonance imaging and transvaginal ultrasonography in patients with an adnexal mass and chronic pelvic pain or infertility.
• OP06.01: Transvaginal ultrasonography and pelvic adhesions in patients with cystic ovarian endometriosis.
• OP16.03: Reproducibility of different patterns of benign ovarian masses assessed by transvaginal ultrasonography evaluated by several operators with different degree of experience.
• OP16.07: Intraobserver and interobserver agreement of B-mode typical ultrasonographic patterns suggestive of presence of ovarian malignancy.
• Oxytocin induces penile erection when injected into the ventral tegmental area of male rats: role of nitric oxide and cyclic GMP.
• Photosynthetic H2 metabolism in Chlamydomonas reinhardtii (unicellular green algae).
• Risk assessment does not explain high prevalence of gestational diabetes mellitus in a large group of Sardinian women.
• Sorption processes and XRD analysis of a natural zeolite exchanged with Pb(2+), Cd(2+) and Zn(2+) cations.
• The screening of embryonic viability in early asymptomatic pregnancy by a single endosonographic scan associated with plasma human chorionic gonadotropin determination.
• The screening of tubal abnormalities in the infertile couple.
• Three-dimensional quantification of tumor vascularity as a tertiary test after B-mode and power Doppler evaluation for detection of ovarian cancer.
• Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome.
• [Chlamydia infection]